Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Debt / NOTE 2.500% 2/1
-
Number of holders
-
9
-
Total 13F principal, excl. options
-
21,188,000
-
Principal change
-
-420,000
-
Total reported value, excl. options
-
$21,933,000
-
Value change
-
-$8,463,193
-
Number of buys
-
2
-
Number of sells
-
-3
-
Price
-
$1.00
Significant Holders of AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 as of Q2 2018
11 filings reported holding 00163UAA4 - AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 as of Q2 2018.
AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 has 9 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $21,188,000 of principal
.
Largest 10 bondholders include Birch Grove Capital LP ($7,424,000 of principal), Bruce & Co., Inc. ($5,500,000 of principal), TENOR CAPITAL MANAGEMENT Co., L.P. ($5,124,000 of principal), JPMORGAN CHASE & CO ($1,765,000 of principal), SONORA INVESTMENT MANAGEMENT, LLC ($1,365,000 of principal), ROYAL BANK OF CANADA ($4,000 of principal), BANK OF AMERICA CORP /DE/ ($3,000 of principal), MORGAN STANLEY ($2,000 of principal), North Star Investment Management Corp. ($1,000 of principal), and Opaleye Management Inc. ($0 of principal).
This table shows the top 9 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.